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Abstract
Background: Activation of heme oxygenase-1 (HO-1) has been proved to reduce damages to the liver in ischemia
reperfusion injury. The objective of present study was to determine whether clinic relevant doses of isoflurane treatment
could be sufficient to activate HO-1 inducing, which confers protective effect against hepatic ischemia-reperfusion injury.
Methods: The hepatic artery and portal vein to the left and the median liver lobes of forty male Sprague-Dawley
rats were occluded for 60 minutes. Reperfusion was allowed for 4 hours before the animal subjects were sacrificed.
Six groups (n = 12) were included in the study. A negative control group received sham operation and positive
control group a standard ischemia-reperfusion regimen. The third group was pretreated with isoflurane prior to the
ischemia-reperfusion. The fourth group received an HO-1 inhibitor zinc protoporphyrin (Znpp) prior to the
isoflurane pretreatment and the ischemia-reperfusion. The fifth group received Znpp alone before ischemia-
reperfusion procedure, and the sixth group was administrated with a HO-1 inducer hemin prior to IR. HO-1 in the
liver was measured using an enzymatic activity assay, a Western blot analysis, as well as immunohistochemical
method. Extent of liver damage was estimated by determination of the serum transaminases, liver lipid
peroxidation and hepatic histology. Infiltration of the liver by neutrophils was measured using a myeloperoxidase
activity assay. TNFa mRNA in the liver was measured using RT-PCR.
Results: Isoflurane pretreatment significantly attenuated the hepatic injuries and inflammatory responses caused by
the ischemia reperfusion. Selectively inhibiting HO-1 with ZnPP completed blocked the protective effects of
isoflurane. Inducing HO-1 with hemin alone produced protective effects similar in magnitude to that of isoflurane.
Conclusions: Clinic relevant doses of isoflurane attenuate ischemia reperfusion injury in rats by increasing the HO-
1 expression and activity.
Background
The heme oxygenase (HO) has been shown to limit
reperfusion injury after experimental systemic and regio-
nal hepatic ischemia[1]. Heme oxygenase 1(HO-1) is the
only inducible form of HO family and its gene expres-
sion is up-regulated in many tissues exposed to a wide
spectrum of noxious stimuli, including physical (irradia-
tion, hyperthermia, etc.), chemical (heavy metals, carbon
tetrachloride, etc.), and physiological (hypoxia, endotox-
emia, etc.) insults. HO-1 catalyzes the oxidation of heme
to biliverdin-IXa, iron, and carbon monoxide, which
exerts its antioxidative, anti-inflammatory, antiapoptotic,
and vasodilatory effects. Activation of HO-1 has also
been shown to reduce damages to the liver caused by a
multitude of factors, including hemorrhagic shock,
endotoxemia, acetaminophen, and IR[2-10]. Therefore,
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S c h m i d te ta l . [ 1 1 ]h a v ec o n f i r m e dt h a tp r e t r e a t m e n t
with isoflurane (ISO) induces hepatic HO-1 expression
and thereby protects rat lives from IR injury. However, a
rather long ISO pretreatment time of 5.5 hours and a
high dose of ISO (2.4 MAC) was required in that study.
Whether shorter time intervals or lower concentrations
of ISO treatment could be sufficient to activate HO-1
and confer protective effect still needs to be evaluated.
In the current study, a pharmacological approach was
used to explore there was a cause-effect relationship
between HO-1 induction and cellular protection in a rat
model of partial hepatic ischemia followed by reperfu-
sion. Specifically, effects of the selective HO-1 inhibitor
zinc protoporphyrin (Znpp) and the selective HO-1
inducer hemin, and their interaction with isoflurane pre-
treatment were also examined under hepatic IR process.
Methods
1 Experimental animals
Male Sprague-Dawley rats (8-10 weeks, 180-220 g) from
the Experimental Animal Center, the Chinese National
Institute of Medicine (Shanghai, China) were used. Ani-
mals were housed in an air-conditioned room at a tem-
perature of 22-25°C, with unlimited access to tap-water
and standard rat chow. Food was removed from the
cages at 12 hours prior to the experiments. The experi-
mental protocol was approved by the Animal Care and
Scientific Committee of the Second Military Medical
University, Shanghai, China.
2 Partial hepatic ischemia and reperfusion
A model of segmental (70%) hepatic ischemia was used
as previously described[12]. After laparotomy with a
midline incision under anesthesia with sodium pento-
barbital (40 mg/kg, i.p.), the ligaments around the liver
were located and disconnected. The hepatic artery, por-
tal vein, and bile duct to the left and median hepatic
lobes were carefully revealed, and occluded with an
atraumatic vascular clamp. The clamp was removed 60
minutes afterward to allow reperfusion. The incision
was closed with sutures during the reperfusion. Body
temperature was maintained at 36-37°C (rectal) by a
heating lamp throughout the entire procedure. Animal
subjects were sacrificed 4 hours after reperfusion
started.
3 Isoflurane treatment
A home-made plexiglass box was used to deliver isoflur-
ane (Abbott Laboratories. Abbott Park, Illinois). Dimen-
sions of the box were 50 × 15 × 15 cm
3,w i t hi n -a n d
out-flow at the opposite long ends. Air sample was
taken from a hole adjacent to the air outlet. Two holes
(10 cm in diameter) sealed with rubber gloves on a side
panel were used for maneuvering the rats. Temperature
was maintained at 35-37°C using light bulbs and partial
pressure of CO2 was maintained at < 0.05% atm with
natrica calx. An air/oxygen (35%) mixed gas was deliv-
ered at a flow rate of 3 L/min.
Isoflurane was delivered with the air/oxygen mixture
using an agent-specific vaporizer (Datex-Ohmeda; Madi-
son, WI). Rats were placed into the box 15 minutes
after the isoflurane concentration reached a steady level
of 1.4%. Concentrations of isoflurane and oxygen were
measured continuously using a Datex respiratory gas
analyzer (Datex Instrumentarium; Helsinki, Finland).
4 Experimental groups
In addition to a sham operation group, the study was
comprised of 5 more groups (n = 12 in each group).
The first group received a standard ischemia-reperfusion
procedure, and served as a positive control. The second
group was pretreated with 1.4% isoflurane for 30 min-
utes prior to the ischemia-reperfusion regimen. The
treatment to the third group was identical to the isoflur-
ane group, except that the animal subjects received an
intraperitoneal injection (i.p.) of selective HO-1 inhibitor
zinc protoporphyrin (Znpp; 25 μmol/kg; Sigma Chemi-
cals, Germany) at 1 hour prior to isoflurane. Animals in
the fourth group were injected 25 μmol/kg of Znpp i.p.
at 1.5 hour before IR. The fifth group received an injec-
tion of the HO-1 inductor hemin (50 mg/kg; Sigma, St.
Louis, MO) i.p. 24 hours prior to IR. All these animals
e x c e p tt h a ti ns h a mg r o u ps u b s e q u e n t l yu n d e r w e n tt h e
same IR procedure as the first group.
5 Sample collections
Four hours after the reperfusion started, rats received an
additional dose of sodium pentobarbital (40 mg/kg, i.p.),
and were sacrificed by severing the abdominal aorta.
Serum were collected and stored at -20°C. The median
lobe of the liver was fixed with 10% formalin and
imbedded with paraffin. The left lobe were rapidly fro-
zen in liquid nitrogen and stored at -80°C.
6 Hepatic HO-1 activity assay
HO-1 activity was assessed using a method reported
previously[13-16]. Liver tissue was homogenized in 4
volumes of a phosphate buffer (0.1 mM KH2PO4;p H
7.4) briefly using an ultrasonic homogenizer (Ultratur-
rax; Janke and Kunkel, Staufen, Germany). The homo-
genate was centrifuged at 10,000 g at 4°C for 20
minutes. The supernatant was used for the measure-
ment of HO-1 activity. Final concentration of the reac-
tion buffer consisted of 0.8 mM NADPH, 2 mM
glucose-6-phosphate, 0.002 U/mL glucose-6-phosphate
dehydrogenase, and 20 μM hemin. The reaction
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100 μl liver cytosol from normal rat as a source of bili-
verdin reductase. Incubation was carried out in a com-
pletely dark room for 60 minutes at 37°C. The reaction
was terminated by immersion of the test tubes in an
ice-bath. For extraction of bilirubin, the tubes were
mixed thoroughly and it was followed by centrifugation
of the tubes at 13,000 rpm for 5 minutes. The chloro-
form layers were scanned on a spectrophotometer at
464 nm minus the background at 530 nm. Enzymatic
activity was expressed as pmol/mg protein/hr.
7 Western blot analysis of HO-1
Liver samples were homogenized in 5 volumes of 10
mM Tris buffer (pH 7.4) containing 1% Triton X-100,
0.5% NP-40, 1 mM EGTA, 1 mM EDTA, 150 mM NaCl
and 1 mM PMSF. The protein concentration in liver
homogenate was determined using a Bradford assay
(Nanjing Jiancheng Bioengineering Institute, Nanjing,
China). The homogenate was centrifuged at 16,500 g for
15 minutes. Supernatant containing 30 μgp r o t e i nw a s
subjected to 12% SDS-PAGE. Separated protein bands
were transferred onto an nitrocellulose filter. The filter
was blocked with 3% non-fat milk, and incubated with a
rabbit-anti-mouse multiclonal antibody against the HO-
1 (dilution 1:2000; ABCAM; Cambridge, UK) for 2
hours. After washing with TBST, the filter was incu-
bated with the secondary antibody (peroxidase labeled
sheep-anti-rabbit IgG) at a dilution of 1:2000 for 1 hour.
Chemoluminescence agent A was mixed with B at equal
volume and evenly smeared onto the filter. The chemi-
luminescence signals captured by exposure to an X-ray
film were digitized and then analyzed by a Chemi-Smart
3000 (Vilber Lourmat; Marne-la-Vallée, France).
8 Serum transaminases, hepatic myeloperoxidase,
malondialdehyde and TNFa mRNA real-time RT-PCR
Serum alanine aminotransferase (ALT) and aspartate
aminotransferase(AST) levels were determined with an
autoanalyzer (Model 7600, Hitachi Co.; Tokyo, Japan).
Hepatic tissue of weight of 100 mg was homogenized in
900 μl phosphate buffer (pH 7.4). The homogenate was
centrifuged at 4,000 g for 10 minutes. Hepatic tissue
change of myeloperoxidase (MPO) and malondialdehyde
(MDA) were assessed by biochemical kits purchased
commercially (Nan-Jing Jiancheng Biochemicals Ltd,
China). The detection ranges were 0-100 U.ml-1 with a
sensitivity of 1 U/ml for MPO, and 0-200 mmol/l with a
sensitivity of 1 mmol/l for MDA.
Total RNA was extracted from liver using the Trizol
reagent (Takara Bio Inc, Japan) as described in the man-
ufacturer’s instructions. TNF-a mRNA were quantified
in duplicate by SYBR green two-step, real-time RT-PCR.
Briefly, following removal of potentially contaminating
DNA using DNase I (Invitrogen, Carlsbad, CA), 1 μgo f
RNA from each sample was used for reverse transcrip-
tion with oligo dT (Invitrogen, Carlsbad, CA) and
Superscript II (Invitrogen, Carlsbad, CA) to generate
first-strand cDNA. The PCR reaction mixture was pre-
pared using SYBR green PCR Master Mix (Applied Bio-
systems, Foster City, CA) using primers as follows:
TNF-a 5’-CCCGGAATGTCGATGCCTGAGTG-3’,a n d
5’-CGCCCCGGCCTTCCAAATAAAT-3’;T h e r m a l
cycling conditions were 10 minutes, at 95°C, which was
followed by 40 cycles of 95°C for 15 seconds and 60°C
for 1 minute on a sequence detection system (ABI
PRISM 7000; Applied Biosystems, Foster City, CA).
Each expression gene was normalized with GAPDH
mRNA using a Delta-Delta CT method.
9 Histology examination and immunohistology of HO-1
All the histopathology and immunohistologic examina-
tion were performed by a blinded pathologist to identify
underlying necrosis and apoptosis status or other types
of injury. Liver samples were excised from the anterior
edge of the left lobe 120 minutes after reperfusion.
Small portions (0.5 cm × 0.5 cm) were fixed immedi-
ately in 10% buffered par formaldehyde (pH 7.2) and
embedded in paraffin. These portions were cut into 4
μm thick sections and stained with hematoxylin and
eosin (H&E). High-powered microscopy (1 × 200) was
used to examine theses sections for the following signs
of liver injury: condensation of nuclei (nuclear pyknosis),
loss of hepatocellular borders, or areas of necrosis, A
score determined by dividing the measured necrotic
area by the total area of the field using Image-Pro-Plus
®
Software (Media Cybernetics Inc, Bethesda, MD) was
obtained. HO-1 immuno-reactivity was examined using
an Elivision
TM Plus Broad Spectrum kit (Fujian Maixin
Biological Technology; Fujian, China). Tissue sections
were incubated at room temperature with 3% hydrogen
peroxide to deactivate endogenous peroxidases after
deparaffinage and re-hydration. Sections were dipped
into an antigen retrieval buffer (10 mM sodium citrate;
pH 6.0) and underwent warm retrieval in a microwave
oven at 95-100°C for 10 minutes. Sections were incu-
bated with a rabbit-anti-mouse HO-1 antibody (dilution
1:100; ABCAM; Cambridge, UK) at room temperature
for one hour. After washing with PBS, a polymer enhan-
cer and an anti-rabbit IgG labelled with horseradish per-
oxidase was applied. HO-1 was visualized as buffy
granules in the cytoplasma using a DAB kit (Fujian
Maixin Biological Technology).
10 Statistical analyses
Data analysis was performed with a personal computer
with statistical software package (Prism version 4.0;
Graph-Pad Software, San Diego, CA). Data are
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and the Student-Newman-Keuls q test were used to
compare values among all groups. Serum enzymes and
peroxidation and TNF alpha mRNA variables were ana-
lyzed using one way analysis of variance with Student-
Newman-Keuls test. Statistical differences were consid-
ered significant if the P value was less than 0.05. All P
values were results of two-sided tests.
Results
1 Effects of isoflurane preconditioning on the hepatic HO-
1ativity and expression
The ischemia/reperfusion regimen significantly increased
the hepatic HO-1 activity (Figure 1A). Isoflurane pre-
treatment augmented the HO-1 activity response
induced by the ischemia/reperfusion. Administration of
the HO-1 inhibitor Znpp, prior to the isoflurane pre-
treatment or pretreatment of Znpp alone significantly
reduced the HO-1 activity (p < 0.05, compared to IR).
Pretreatment with the HO-1 inducer hemin increased
the hepatic HO-1 activity to a level similar to that in
the isoflurane group.
Changes in the HO-1 protein level, as determined by
the Western blot analysis ((Figure 1B). HO-1 was barely
detectable under the baseline condition. IR increased
the amount of HO-1 significantly. Isoflurane or hemin
pretreatment further increased the expression of HO-1,
while no difference in the expression of HO-1 protein
level in Znpp/isoflurane and Znpp groups could be
found when compared with IR group. Results from the
immunohistology were also in line with the changes in
enzymatic activity as shown in figure 1C. Very few HO-
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Figure 1 Effect of isoflurane preconditioning on liver heme oxygenase-1(HO-1) after ischemia reperfusion injury (IR) (n = 12 each
group). (A) The HO-1 activity in the liver. Both isoflurane and hemin pretreatment augmented the HO-1 activity response, while administration
of the HO-1 inhibitor zinc protoporphyrin (Znpp), prior to the isoflurane pretreatment or Znpp alone significantly decreased the HO-1 activity (p
< 0.05, vs. IR). (B) Western blot analysis of HO-1in liver. Western blotting showed an increase in HO-1 protein expression in the groups of
isoflurane and hemin (* P < 0.05 vs. IR). (C) Immunohistochemical detection of HO-1 in the liver. Hepatic HO-1 positive cells were defined as
stained with brown in cytoplasm (black arrows). There was an increase in HO-1 expression in isoflurane and hemin pretreated groups compared
in IR, it also showed a decrease in HO-1protein expression in both Znpp pretreated groups compared with isoflurane group (Magnification:
400×. Scale bar = 100 μm).
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increased the number of HO-1 positive cells, while iso-
flurane or hemin substantially increased the number of
HO-1 positive cells in comparison to the IR group, and
Znpp decreased HO-1 expression when compared with
isoflurane group.
2 Effects of isoflurane preconditioning on hepatic injury
after ischemia reperfusion procedure
The ischemia/reperfusion regimen significantly increased
the serum transaminases, hepatic TNFa mRNA level,
myeloperoxidase and malonaldehyde activity (shown in
table 1). All these changes were attenuated significantly
by the pretreatment with isoflurane and hemin. Admin-
istration of Znpp completed reversed these effects. Four
hours after reperfusion, the liver histology of isoflurane
and hemin pretreated groups exhibited fewer and smal-
ler areas of necrosis and structural derangement around
the central vein as compared to the IR group, while
there were no obvious histological difference noticed in
Znpp/isoflurane and Znpp groups when compared to
the IR((Figure 2).
Discussion
Results from the current study demonstrated that 1.4%
ISO for 30 minutes pretreatment before ischemia signifi-
cantly increased HO-1 activity in the liver. The increase
in enzymatic activity was associated with an increase in
the HO-1 protein levels. We also found that increased
HO-1 activity and expression by isoflurane was asso-
ciated with lower levels of aminotransferases and TNFa
mRNA, decreased lipid peroxidation and myeloperoxi-
dase activity in the liver.
HO-1 expression could be induced including solitude
hypoxia or hyperoxia. Much work has been done and
aimed to assess whether hypoxia alone could cause any
significant induction of HO-1 or not. [11,14-19] Yama-
saki’s [19] study in which used low concentration of iso-
flurane (0.42%) to induce HO-1 in rats’ hypoxia model,
finding isoflurane-hypoxia treatment caused a minor
increase at 6-8 hours. In order to exclude these two pos-
sible factors, we used a normal oxygen concentration of
35% which was also in according with clinical applica-
tion. We also increased the concentration of isoflurane
in order to shorten the time of isoflurane treatment.
Thus, effects of isoflurane might indeed be clinically
relevant. Furthermore, using the inhibitor of HO-1
Znpp, could completely blocked the increase of HO-1
activity and expression when compared with isoflurane
pretreatment group. The effects of isoflurane on all
measures of liver damage were also completely abolished
by Znpp, which strongly suggested that the protective
effects of isoflurane were mediated by an increase in
HO-1 activity and expression. Effects of pretreatment
with the HO-1 inducer hemin alone produced beneficial
effects similar to isoflurane, further indicating a pivotal
role of HO-1 in the cytoprotective effects under IR.
HO is an almost ubiquitous enzyme that catalyzes the
breakdown of heme to equimolar amount of biliverdin,
carbon monoxide (CO) and ferrous iron. Among the 3
mammalian isoforms of HO, only the HO-1 is inducible.
HO-1 is a major protective mechanism that responds to
a wide selection of noxious stimuli, and most notably,
oxidative and inflammatory tissue damages[4]. Activa-
tion of HO-1 has been shown to minimize the damage
after ischemia followed by reperfusion in a number of
organ systems[20,21]. In general, IR damage is caused
primarily by free radicals. Correspondingly, increased
production of biliverdin as a scavenger for free radicals
is considered the most important mechanism by which
HO-1 counteracts the IR damage[22]. In this particular
study, we did not examine the specific role of biliverdin.
However many previous studies have demonstrated the
importance of this endogenous anti-oxidant.
In addition to the formation of free radicals, IR
damage in the liver consists of two additional factors,
namely micro-circulation and inflammatory response.
We did not directly examine micro-circulation in this
study[23,24]. Microscopic examination of hepatic slices,
however, indicated that improved micro-circulation
m i g h tb eo n eo ft h em e c h a n i s m st h r o u g hw h i c hH O - 1
activation alleviates the IR damage. Thus, the degree of
sinosoidal congestion was correlated negatively with
HO-1 activity and expression. More specifically,
Table 1 Serum aminotransferases, liver lipid peroxdation, myeloperoxidase activity and TNFa mRNA when pretreated
with isoflurane
Sham IR ISO Znpp/ISO Znpp Hemin
ALT (IU.l
-1) 39 ± 14* 3336 ± 393 2787 ± 209* 3677 ± 249 3106 ± 327 2290 ± 334*
AST (IU.l
-1) 31 ± 25* 3792 ± 326 2867 ± 475* 4149 ± 401 3904 ± 414 2149 ± 509*
Hepatic TNFa mRNA (fold of Sham) - 12.8 ± 7.2 6.7 ± 3.5* 14.5 ± 7.8 13.6 ± 6.9 7.5 ± 4.9*
MDA (μmol.l
-1) 4.8 ± 1.6* 29.6 ± 7.2 13.1 ± 1.8* 39.4 ± 10.6 37.6 ± 8.8 19.8 ± 4.7*
MPO (U.g tissue
-1) 1.5 ± 0.3* 3.5 ± 0.3 2.2 ± 0.4* 3.7 ± 0.5 4.1 ± 0.7 2.0 ± 0.3*
* P < 0.05 vs. IR group value. Values are mean ± SD of 12 animals in each group.
IR = ischemia reperfusion injury; ISO = isoflurane; Znpp = zinc protoporphyrin; ALT = alanine aminotransferase; AST = aspartate aminotransferase; TNFa = tumor
necrosis factor a; MDA = malondialdehyde; MPO = myeloperoxidase.
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alleviated by isoflurane and the HO-1 inducer hemin.
[25,26] Also, effects of isoflurane were blocked by Znpp.
These results were circumstantial in nature, but did
point towards a potential involvement of micro-circula-
tion improvement via CO.
The inflammatory response serves an important func-
tion of homeostasis after the IR. Ischemia of the liver
invariably leads to an influx of bacteria and associated
toxins upon reperfusion because of the strategic locali-
zation of the liver in blood supply to the entire gastroin-
testinal tract. [23,25] The inflammatory response after
the IR is initiated in the Kupffer cells. Activated Kupffer
cells release massive amount of free radicals and pro-
inflammatory cytokines. The resulting inflammatory
response serves to prevent the bacteria and their pro-
ducts from entering the systemic circulation after the
IR. However, convincing evidence has demonstrated
that the massive inflammatory response is also a major
cause of hepatic injuries after the IR[4,26].
The fact that TNFa in the liver increased significantly
after the IR in our experiments suggested that the liver
damage after the IR is indeed partially mediated by the
inflammatory responses. Infiltration of the liver by neu-
trophils further supported a critical role of inflammation
in the IR injuries. [27] Considering the aforementioned
actions of CO in regulating inflammatory responses,[28]
these results strongly suggested that the anti-inflamma-
tory action of increased production of CO is a major
contributor to the protective action of HO-1 [29].
Based on the observations that pretreatment with low
doses of pro-inflammatory cytokines prior to the IR pre-
vents activity burst of Kupffer cells, it is hypothesized that
isoflurane may counteract the IR damage through the
same mechanism as preconditioning[30,31]. Thus, modest
activation of Kupffer cells prior to the IR creates a
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Figure 2 Effects of isoflurane preconditioning on hepatic histology after ischemia reperfusion (IR) procedure (n = 12 in each group).
(A) Hepatic tissue histological changes were processed with H&E staining for light microscopy examination. Photograph depicted typical pattern
of focal necrosis (black arrows) after ischemic degeneration of hepatocytes around the central venous area. More seriously necrosis was shown
in both zinc protoporphyrin (Znpp) pretreated and IR groups compared in sham group. Magnification: 200 × Scale bar = 200 μm. (B) There
was no obvious necrosis in sham group. Areas of necrosis were significantly lower in isoflurane and hemin pretreated groups than in IR group
(*P < 0.05 vs. IR).
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when IR insult actually happens[32]. This hypothesis
seems plausible. However, whether preconditioning indeed
occurs in vivo remains controversial[33]. Experiments
addressing this possibility are currently being conducted
in this laboratory to test the pre-conditioning hypothesis.
Conclusions
In summary, our results confirmed that approximately 1
MAC (1.4%) of isoflurane could enough protecting the
liver from the IR injuries; and increase the activity and
the expression of HO-1 in hepatocytes. This study also
demonstrated that the protective effects of HO-1 against
the liver IR damage are mediated by the activation of
HO-1. Based on these findings that HO-1 is believed to
be, a promising molecular target in developing novel
treatment and prevention for hepatic IR injuries.
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